Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-17 6:10 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $0.3523 | $58 | 22,563 (Direct) | View |
| 2024-10-03 Sale | 2024-10-03 9:53 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 5,556 | $0.55 | $3,056 | 19,601 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:19 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 138 | $0.6908 | $95 | 7,034 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:25 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 155 | $1.285 | $199 | 7,172 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $2.6211 | $432 | 16,327 (Direct) | View |
| 2023-03-15 Sale | 2023-03-16 5:59 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 845 | $19.7 | $16,642 | 48,492 (Direct) | View |
| 2023-01-20 Sale | 2023-01-24 8:04 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 29,713 | $30 | $891,390 | 29,712 (Direct) | View |
| 2021-02-17 Sale | 2021-02-19 7:35 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $55.58 | $1,389,459 | 80,472 (Direct) | View |
| 2021-01-19 Sale | 2021-01-21 4:15 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $49.47 | $1,236,719 | 74,425 (Direct) | View |
| 2020-12-28 Sale | 2020-12-30 4:15 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $51.45 | $1,286,157 | 99,425 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-14 Exercise | 2024-12-17 6:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 22,563 (Direct) | View |
| 2024-09-17 Option Award | 2024-10-03 9:53 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 21,250 | $0 | 19,601 (Direct) | View |
| 2024-09-14 Exercise | 2024-09-17 7:19 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 7,034 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:25 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 521 | $0 | 7,172 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 2,771 | $0 | 16,327 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:36 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 5:59 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 2,084 | $0 | 48,492 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:59 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 41,000 | $0 | 48,492 (Direct) | View |
| 2023-01-20 Exercise | 2023-01-24 8:04 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 29,713 | $0.41 | 29,712 (Direct) | View |
| 2023-01-20 Exercise | 2023-01-24 8:04 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 29,713 | $0 | 29,712 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 4:20 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 8,337 | $0 | 8,337 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-29 8:53 pm | N/A 2031-03-25 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-02-17 Exercise | 2021-02-19 7:35 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 15,000 | $0.41 | 80,472 (Direct) | View |
| 2021-02-17 Exercise | 2021-02-19 7:35 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 10,000 | $11 | 80,472 (Direct) | View |
| 2021-02-17 Exercise | 2021-02-19 7:35 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $0 | 80,472 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 4:15 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $0.41 | 74,425 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-21 4:15 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $0 | 74,425 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:15 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $0.41 | 99,425 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-30 4:15 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 25,000 | $0 | 99,425 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-28 4:15 pm | N/A 2030-05-25 | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 40,000 | $0 | 40,000 (Direct) | View |